---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-048658"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-04-26T23:59:59+00:00"
generated_at: "2026-06-03T06:38:39.974082+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Renalytix closes second tranche of private placement, raises ~$7M gross

## Summary
- Second Tranche of 26,815,841 ordinary shares at £0.20 each closed on April 24, 2024, following shareholder approval.
- Gross proceeds from Second Tranche ~$7M; net proceeds expected to extend cash runway into calendar Q4 2024.
- Post-issuance total ordinary shares outstanding: 154,368,191.
- Company to file resale registration statement with SEC within 45 days of Second Closing.
- First Tranche of 19,986,031 shares closed March 14, 2024; combined offering proceeds extend runway.

## SEC filing metadata
- accession: 0000950170-24-048658
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-04-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/0000950170-24-048658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/rnlx-20240424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-048658
- JSON: https://secwatch.observer/filing/0000950170-24-048658.json
- Plain text: https://secwatch.observer/filing/0000950170-24-048658.txt

## Key facts
- Material Agreements
  Renalytix plc entered into Placing Agreement with Stifel Nicolaus Europe Limited valued at up to an aggregate of 46,801,872 ordinary shares (effective 2024-03-12).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Stifel Nicolaus Europe Limited
  - Value: up to an aggregate of 46,801,872 ordinary shares
  - Effective: 2024-03-12
  source text: on March 12, 2024, Renalytix plc (the “ Company ”) entered into a Placing Agreement (the “ Placing Agreement ”) with Stifel Nicolaus Europe Limited
  evidence_url: https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/0000950170-24-048658-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.